• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA’s new plan to study opioids’ effectiveness faces resistance

cafead

Administrator
Staff member
  • cafead   Apr 19, 2023 at 10:02: PM
via The Food and Drug Administration’s latest plan to study whether opioids are effective as a chronic pain treatment is facing significant resistance from addiction and pain care experts.

article source
 

<